Association of carbon monoxide levels with allergic diseases in children

Jihyun Kim1, Youngshin Han, Sung Chul Seo

  • 1Department of Pediatrics, Samsung Medical Center, Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Insights

Exposure to carbon monoxide (CO) in infancy is linked to a higher risk of developing allergic rhinitis. Higher CO levels in the past year also increased the likelihood of current atopic dermatitis symptoms in children.

Area of Science:

  • Environmental Health
  • Pediatric Allergy
  • Epidemiology

Background:

  • Air pollution is a suspected factor in the development and worsening of allergic diseases.
  • Understanding the specific impact of air pollutants on childhood allergies is crucial for public health.

Purpose of the Study:

  • To examine the link between early-life exposure to outdoor air pollution and the development of allergic diseases.
  • To assess the association between residential air pollution levels and current allergy symptoms in children.

Main Methods:

  • A nationwide cross-sectional survey of 6- to 7-year-old children was conducted.
  • Data from 1828 infants and 1894 children living near air quality monitoring sites were analyzed.
  • Allergic disease prevalence was assessed via questionnaires and pediatrician examinations; air pollutant data (SO2, NO2, O3, CO, PM) were obtained.

Main Results:

  • A 100 ppb increase in mean daily carbon monoxide (CO) during infancy correlated with a 1.10 odds ratio for lifetime allergic rhinitis.
  • A 1 ppm increase in annual average CO over the past 12 months showed an 8.11 odds ratio for current atopic dermatitis.
  • No significant associations were found for other measured air pollutants.

Conclusions:

  • Infant exposure to elevated carbon monoxide (CO) levels elevates the risk for allergic rhinitis.
  • Increased CO exposure in the preceding year is associated with a higher risk of current atopic dermatitis symptoms in children.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.4K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.8K
Allergic Reactions02:06

Allergic Reactions

Overview
33.5K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
169